Lynx1 Capital Management LP
Annual return '25
+15.2%
SPY '25
+17.7%
Alpha
-2.6ptsvs SPY
Invested
$1.3B
Holdings
23
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 2 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$STOK
STOKE THERAPEUTICS INC
Q4 2025: Exited (was 5.40M shares)
27.9%
02
$CGEM
CULLINAN THERAPEUTICS INC
Q4 2025: Exited (was 5.77M shares)
22.9%
03
$AGIO
AGIOS PHARMACEUTICALS INC
Held since at least Q1 2024
15.9%
04
$GHRS
GH RESEARCH PLC
Q4 2025: Exited (was 8.60M shares)
13.6%
05
$DNLI
DENALI THERAPEUTICS INC
Q4 2025: Exited (was 261.7k shares)
6.5%
06
$CCCC
C4 THERAPEUTICS INC
Q4 2025: Exited (was 7.10M shares)
3.3%
07
$KRRO
KORRO BIO INC
Held since at least Q1 2024
3.1%
08
$TCRX
TSCAN THERAPEUTICS INC
Q4 2025: Exited (was 7.86M shares)
1.5%
09
$XNCR
XENCOR INC
Held since at least Q1 2024
1.2%
10
$DTIL
PRECISION BIOSCIENCES INC
Q4 2025: Exited (was 1.04M shares)
1.0%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:25 UTC.